Summary
The evidence that chronic exposure to inhalational anaesthetic agents may be associated with psychomotor, hepatic and renal dysfunction, to increased susceptibility to infections and neoplastic disease, and to an increased incidence of miscarriages and foetal abnormalities, is discussed. The risk to pregnant women seems greatest after exposure to rather high concentrations of nitrous oxide. Although it is not suggested that all laboratory premises will be equally at risk, such levels as 400 ppm halothane and 8000 ppm nitrous oxide can build up in small poorlyventilated rooms when these agents are used for several hours at a time. A strong plea is entered for all to be aware of the hazard and to ensure that good ventilation and preferably, purpose-built scavenging equipment are installed wherever inhalational agents are used.
That some inhalational anaesthetics are dangerous because of their low flash-point and flammability is well recognized and merely needs restating here: failure to take the necessary precautions amounts to frank negligence. In contrast, the risks of chronic exposure to these agents at low environmental concentrations are more subtle and poorly defined.
Chronic inhalation has been accused of causing: biotransformation and accumulation of metabolites which can reduce psychomotor performance and deterioration in the central nervous, renal and hepatic systems; interference with enzyme systems and important metabolic pathways; depression of myeloid and leukocytic cells and a general damping of immune responses; increased susceptibility to neoplastic disease; impotence and depressed spermatogenesis in males; and an increased incidence of miscarriages, foetal abnormalities and skeletal deformities in the offspring of women. However, there is no sound evidence for most of these accusations. Much of the epidemiological and experimental evidence is equivocal or even contradictory, and interpretation ranges from the frankly alarmist to the bland and dismissive. Confusion arises and incorrect conclusions are often drawn because of a failure to distinguish between acute or repeated exposure to actual or near-anaesthetic dosages and chronic exposure to operating-area pollution levels. It must be self-evident that we should appreciate the risks and take appropriate steps to minimize them.
The nature of the health hazard Flammability and explosive hazards The flammability of diethyl-ether and cyclopropane is well known, but accidents still happen. It is worth emphasizing that diethyl-ether forms explosive mixtures not only with oxygen, but also with air and nitrous oxide. Being heavier than air, it can collect in sufficient concentration in poorly-ventilated corners to present a hazard for some hours after first released. It has even been known to drift into adjacent rooms to interrupt the morning coffee and cigarette. Probably because it too forms explosive mixtures with air or oxygen and has to be recirculated within closed rebreathing systems, cyclopropane is now little used in animal anaesthesia. Finally, although again it is little used, trichloroethylene is dangerous because it is decomposed by alkalis and heat, breaking down to form dichloroacetylene which is explosive, and to phosgene and carbon monoxide which are highly toxic-it must never therefore be used with soda-lime in closed circuits.
Neurological dysfunction
It has been suggested that trace concentrations of inhalational agents adversely affect perceptual, cognitive and motor skills of operating-theatre personnel (Bruce, Bach & Arbit, 1974) , although the balance of experimental evidence indicates that halothane concentrations far higher than 10 ppm are required to produce detrimental effects (Smith & Shirley, 1978) . However, it is well known that, for example, bromide produced by biotransformation accumulates in appreciable quantities in the blood of anaesthetists exposed to halothane (Duvaldestin et al. 1979) , so that chronic exposure could conceivably prove more depressive. Vaisman (1967) surveyed 303 Russian anaesthetists and reported an unusually high incidence of headache, fatigue, irritability, nausea, insomnia, liver disorders and pruritus, but this was a completely uncontrolled study which must be weighed with scepticism. Similarly, when male dentists using mainly nitrous oxide were questioned (Cohen, Brown & Wu, 1980) , a substantial increase of nonspecific neurological symptoms was reported by those exposed to anaesthetic gases. Since a condition resembling subacute combined degeneration of the spinal cord has also been encountered in 'sniffers' of nitrous oxide (Layzer, 1978) , it is possible but highly unlikely that central nervous system dysfunction could be caused through pollution concentrations of nitrous oxide affecting vitamin BI2 and folate metabolism (Amess, Burman, Rees, Nancekievill & Mollin, 1978; Deacon, Lumb, Muir, Perry & Chanarin, 1979) .
Overall then, even though others have concluded that trace concentrations of gases are unlikely to affect mental performance in the short term (Cook, Smith, Starkweather, Winter & Eger, 1978; Frankhuizen, Vlek, Burm & Rejger, 1978) , there must be some doubts about long-term central nervous system degeneration after chronic exposure to the far higher concentrations of nitrous oxide and halogenated agents which can accumulate in poorly-ventilated premises.
Hepatic and renal dysfunction
There is a strong association between anaesthetic levels of some (but not all) agents and hepatic and renal dysfunction. Most data suggest that toxic effects on the liver and kidneys are caused by the products of metabolic degradation rather than the parent agent itself. Contrary to common belief, inhalational agents are not simply exhaled via the lungs but are metabolized to a varying degree-for instance, although only about 5% of nitrous oxide is thought to be metabolized, it has been shown that nearly 50% of methoxyflurane is degraded in the liver and kidneys. The problem is that these metabolites can be stored by the body so that chronic exposure, even to low pollution concentrations of inhalational agent, might lead to accumulation. For example, studies by Stier, Alter, & Hessler (1964) and Rehder, Forbes & Alter (1967) demonstrated that metabolites of halothane could be recovered from the urine of patients as long as 20 days after anaesthesia. Similarly, Holaday, Rudofsky & Treuhaft (1970) found that metabolites of methoxyflurane were still being excreted 10 days after surgical anaesthesia. Subsequent clinical studies by Corbett & Ball (1971) revealed that exhalation of nitrous oxide occurred as long as 56 hours after anaesthesia.
Whether long retention of low concentrations of these anaesthetic agents is harmful has never been proven. When Cascorbi, Blake & Helrich (1970) investigated the possibility of enzyme induction resulting from chronic exposure to low concentrations of anaesthetic gases, they demonstrated wide variation in rates of metabolism from person to person. Nonspecific stimulation of drug-metabolizing enzymes has Green also been demonstrated in laboratory animals (Van Dyke, 1966; Linde & Berman, 1971 ). Furthermore, Chenoweth, Leong & Sparschu (1972) were able to demonstrate hepatomegaly and histological changes in the livers of rats following chronic exposure to low concentrations of halothane and methoxyflurane. Bruce, Linde & Koepke (1975) found focal lesions in livers of rats exposed daily to halothane and nitrous oxide for 6 weeks, but not in rats exposed to halothane alone . In another study in rodents, halothane produced a greater incidence of hepatic degeneration than isoflurane or diethyl-ether, and it was concluded that metabolites of halothane were the culprits rather than the anaesthetic itself (Stevens et al., 1975) . Electron microscopy has revealed ultrastructural changes in both adult liver and in livers removed from neonatal rats whose mothers had been exposed to halothane throughout pregnancy (Chang, Dudley & Katz, 1974) . Halothane hepatitis is a well-recognized pathological entity (Carney & Van Dyke, 1972; Chang & Katz, 1976) , but is probably associated only with one or more exposures to high anaesthetic concentrations. The lesions almost invariably include centrilobular necrosis, fatty degeneration and metamorphosis, hepatocyte ballooning and inflammatory cell infiltration (Schatzki, Kay & McGavie, 1973) . Similar lesions have been attributed to methoxyflurane but not to enflurane (Byles, Dobkin, Ferguson & Levy, 1971; Harrison, Marsh, Bradshaw, Zietsman & Ivanetich, 1976; Stevens et al., 1977; Clark et al., 1979) . Our own data comparing halothane with enflurane during chronic toxicity studies failed to reveal any hepatotoxicity or nephrotoxicity due to enflurane (Halsey et at., 1981; Green, Monk, Dore & Halsey, 1982) .
A renal syndrome of polyuria, hypernatraemia and loss of weight has been observed in man after anaesthesia with methoxyflurane (Crandell, Pappas & Macdonald, 1966; Mazze, Shue & Jackson, 1971) and it is generally accepted that this is due to a distal tubular lesion produced by inorganic fluoride resulting from biotransformation of that anaesthetic (Mazze, Trudell & Cousins, 1971 ). Although halothane nephrotoxicity has been reported in animals (Raventos, 1965; Chang, Dudley, Lee & Katz, 1975) there is little solid evidence that it occurs in man, and there are no reports of enflurane causing renal dysfunction in any species. Again, it must be emphasized that these changes are unlikely to result from environmental pollution concentrations.
Immunosuppression and susceptibility to i'lfections
Although the observation that inhalation of nitrous oxide for 2-3 days at analgesic concentrations usually results in severe neutropenia was made many years ago (Lassen, Henriksen, Neukirch & Kristensen, 1956 ), a possible mechanism eluded definition until recently. Now it seems fairly certain that nitrous oxide blocks methionine synthesis by reacting with vitamin B12, and thence depresses folate, thymidine and DNA synthesis (Deacon et at., 1978) . This raises the possibility that chronic exposure to nitrous oxide could result in megaloblastic anaemia quite apart from tl"te subacute combined degeneration of the cord referred to above (Nunn, 1979) , although it seems that the EDso for this effect is about 5000 ppm (J. F. Nunn, personal communication).
It has also been suggested that anaesthetics enhance the risk of infection through depression of phagocytosis, probably by rendering neutrophils less deformable and hence less able to undergo transvascular diapedesis (Bruce, 1966 (Bruce, , 1967 . Studies by Humphrey, Wingard & Lang (1969) in rats and mice treated for 24 h with halothane, nitrous oxide and pentobarbitone revealed significant reduction in splenic antibodyproducing cells. Other studies in mice have also shown a marked increase in susceptibility to virus infections (Moudgill, 1973) . The immunosuppressant effect of halothane has been studied in rats (Wingard, Lang & Humphrey, 1967; Wingard, 1973) and in tissue cultures (Nunn, Sharp & Kimball, 1970) , and depression of lymphocyte function demonstrated. Most of these effects have, however, been observed after exposure to rather high concentrations of anaesthetic for a relatively short time, and it is at present impossible to show any definite correlation between chronic exposure and increased susceptibility to respiratory or other infections.
Susceptibility to neoplastic disease
The possibility that inhalational anaesthetics might be carcinogenic has provoked many studies in cell cultures and in animals. Several have investigated their effects on chromosomal breakage or have sought other experimental evidence of mutagenicity, since 90% of carcinogens are also mutagenic (McCann & Ames, 1976) . The results with Ames test and mammalian cell cultures have been negative except with agents containing a vinyl group so, on that evidence, it is likely that only trichloroethylene is a potential carcinogen (Waskell, 1978; Baden & Simmon, 1980 ). Long-term animal studies have also proved negative. Baden, Mazze, Wharton, Rice & Kosek (1979) concluded that lifetime exposure to halothane at its maximum tolerated dose did not lead to increased incidence of neoplasia in mice. Similarly, no increase was caused in rats exposed to 10 ppm halothane and 500 ppm nitrous oxide for 7 h a day,S days a week for 104 weeks (Coate, Ulland & Lewis, 1979) . Even the suspicions generated by the reported findings with isoflurane (Corbett, 1976) have since been dampened by better controlled studies (Eger et ai., 1978) . Apart from one survey of personnel which reported a higher 399 than expected incidence of reticular, endothelial and lymphoid malignancies among anaesthetists (Bruce, Eide, Linde & Eckenhoff, 1968) , and another indicating a 3-fold increase in cancer amongst nurseanaesthetists (Corbett, Cornell, Lieding & Endres, 1973) , the accumulated data from other epidemiological studies recently reviewed by Vessey (1978) failed to reveal any trend toward increased neoplastic disease in anaesthetists, dentists or their chairside assistants. The carcinogenic hazard appears small.
Risks to pregnant women and the unborn child
Finally, in identifying the nature of the hazard we have to consider whether chronic exposure to inhalational agents puts pregnant women at particular risk. Anxiety about this possibility was triggered by Vaisman (1967) , who reported that out of 110 women anaesthetists, 31 had become pregnant during the period covered by her survey and, of those pregnancies no fewer than 18 had ended in spontaneous abortion. This inspired much experimental and epidemiological research, particularly into the abortifacient, foetotoxic and teratogenic risk of chronic exposure to low levels of anaesthetics. The earliest work (Fink, Shepard & Blandau, 1967; Basford & Fink, 1968 ) cast suspicion on nitrous oxide and halothane as teratogens, but more recent experiments in our laboratory (Lansdown, Pope, Halsey & Bateman, 1976; Pope, Halsey, Lansdown, Simmonds & Bateman, 1978) in which pregnant rats were exposed throughout pregnancy to concentrations of anaesthetics at least 500 times those likely to occur in an operating theatre, failed to show any teratogenicity or increased foetal loss. Similarly, no teratogenic or abortifacient effect could be attributed to prolonged exposure to combinations of halothane and nitrous oxide at pollution concentrations (Coate, Kapp & Lewis, 1979) . Exposure to anaesthetic concentrations of nitrous oxide and other agents, however, does cause an increased incidence of abortion and foetal malformation in rodents (Lane et al., 1979) . So far, enflurane has not been accused of such effects and we were unable to demonstrate teratogenicity in rats (Halsey et al., 1981) .
Epidemiological surveys in man have been dogged by statistical artefacts which make the data extremely difficult to interpret (Vessey, 1979; Vessey & Nunn, 1980) . Nevertheless, in spite of methodological shortcomings, including reporting bias and heavily loaded questions, a trend does emerge from the best of them (Cohen, Bellville & Brown, 1971; Knill-Jones, Rodrigues, Moir & Spence, 1972; Corbett, Cornell, Endres & Lieding, 1974; Pharoah, Alberman, Doyle & Chamberlain, 1977; Cohen et al., 1980) . It is reasonably conclusive that there is an increased risk of spontaneous abortion in theatre staff (Spence & Knill-Jones, 1978 Vessey & Nunn, 1980) , but although high pollution concentrations of nitrous oxide may well be the cause, other stress factors might be important.
Levels of pollution in operating areas
The first documentation of polution levels in operating rooms (Linde & Bruce, 1969) reported peak levels of 27 ppm halothane and 428 ppm nitrous oxide. Soon afterwards, Askrog & Petersen (1970) recorded average concentrations of 85 ppm halothane and 7000 ppm nitrous oxide in the inhalation zone of the anaesthetist when a nonrebreathing system was used. In 1971, Corbett & Ball found levels of methoxyflurane in the operating room ranging from 2-10 ppm near to the anaesthetist and from 1-2 ppm around the surgeons; these authors demonstrated that methoxyflurane concentrations could be reduced significantly by the use of a gas trap placed over the expiratory valve, from whence it was vented to suction. Similarly, Whitcher, Cohen & Trudell (1971) demonstrated a 10-fold reduction in atmospheric contamination when using scavenging equipment. Additional studies of environmental concentrations of nitrous oxide (Corbett, 1972) and of trichlorethylene (Corbett, Hamilton & Yoon, 1973) followed. In a recent survey of 20 hospitals in Britain (Davenport, Halsey, Wardley-Smith & Bateman, 1980) , background levels of 0·1-60 ppm halothane and 30-3000 ppm nitrous oxide were measured in the absence of scavenging precautions.
How relevant is this to laboratory conditions? In an attempt to produce the worst likely operating-area pollution, we recently measured halothane concentrations in a small, poorly-ventilated room after supplying a rabbit with 2% halothane in oxygen flowing at 2 litres/min to a tightly-fitting mask via a Magill circuit for 3 h. Such a system is commonly used in laboratory animal anaesthesia. No attempt was made to scavenge or absorb the halothane escaping from the circuit. The concentration near the surgeon was 400 ppm or 7 times the worst concentration encountered in the hospital survey above. Similarly, levels of 250 ppm have been recorded in a poorlyventilated laboratory where rats were anaesthetized with 1·5-2% halothane at a flow rate of only I litre/min (Glen, Cliff & Jamieson, 1980) , and this was reduced to 5 ppm by using a simple scavenging system. As for nitrous oxide, perhaps the data obtained from a survey (Millard & Corbett, 1974) of dental practices, in which levels as high as 7000 ppm were recorded close to the dentist, are most likely to resemble the contamination in laboratory premises. In a similar experiment to find out what was possible, we supplied a rabbit with nitrous oxide at 1 litre/min for 3 h and measured peak concentrations of II 000 ppm.
How practicable would it be to instal inexpensive scavenging equipment, and what levels should we be aiming for anyway? Clearly, there is no 'safe' level of Green contamination since a 'toxic' effect cannot be quantified. No authority in Britain has laid down statutory levels which could then be used in a court of law, and even those recommended in the United States (at present 2 ppm of halothane and 25 ppm of nitrous oxide) would probably fail in a court of law. Equally clearly, all steps should be taken to reduce contamination as far as possible.
The alternative to using closed-circuit rebreathing systems without nitrous oxide can be one of several alternative scavenging methods. First, if a Magill circuit and rubber mask is being used, an adaptor can be placed over the Heidebrink valve with flexible tubing leading to a charcoal adsorber ('Cardiff Aldasorber'; Shirley Aldred & Co. Ltd, Worksop, UK). This removes volatile anaesthetics but not nitrous oxide. The effective life of these adsorbers depends on the amount of volatile agent presented to them, but it has been calculated that their 950 g of charcoal is capable of adsorbing 142 ml of liquid halothane equivalent to a flow of I litre/min of 2% halothane for 26 h . Removal of contaminants will not be complete: halogenated compounds, particularly methoxyflurane, will be absorbed by rubber tubing in the circuit and released into the atmosphere; the mask however well-fitted is bound to leak to some extent; and the malleable plastics used in the scavenging system will also absorb and subsequently release anaesthetics . An alternative to the charcoal adsorber and one which also removes nitrous oxide is to pipe the expired gases via an air-break and control trap to a piped vacuum system, to ventilation outlets, or to an outside window via a small low-flow suction pump. Pumps designed for aerating home aquaria can be modified for this job and cost very little. Suction can even be controlled to remove just enough expired gas from the expiratory limb of an Ayres T-piece.
If open-circuit systems have to be used, for example where the animals are too small to accept endotracheal tubes easily, masks can be manufactured based on the Brown nasal mask (Davis & Parbrook, 1979) or others designed specifically for laboratory animals (McGarrick & Thexton, 1979; Glen et at., 1980) . A complete scavenging unit of similar design can be purchased (J. W. Turner Ltd, Aigburth, UK). These masks are surrounded by an outer jacket to which suction is applied by an extraction pump, thus removing excess and expired gases from the immediate area of the animal. They can then again be ducted to a carbon adsorber or vented to the exterior if they contain nitrous oxide. Conclusions 1. Nitrous oxide is not the innocuous gas which many of us had thought. In the absence of efficient scavenging, its use in laboratories should be reconsidered.
2. Enflurane appears to be the safest of the volatile anaesthetics from the point of view of personnel, but this may well be that it has been less extensively used and tested. 3. Pollution concentrations under laboratory conditions are likely to be far higher than those encountered in hospitals. 4. Given that possibility, the risk to health could be considerably higher among laboratory personnel than in hospital theatre staff. 5. Female staff becoming pregnant or wanting to become pregnant would be well advised to avoid working in areas where high concentrations are likely to accumulate.
6. Effective scavenging should be installed. 7. Finally, commercial organizations should be given every encouragement to develop novel injectable agents such as anaesthetic steroids which do not accumulate or produce tolerance and which, though short-acting, can be given safely as a sequential or continuous infusion for long periods of anaesthesia. It may then become preferable to avoid inhalational anaesthetics altogether in many situations. 
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